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I=~l,l=tbelled GkP.l('/,~36)ar~ide wa~ ¢:ros~.linked to a =p~illc binding protein in rat lunll membrane~ u~in~ di~uccinimidyl ~ul~r=tte. A sin~,le radio. 
iat~lled b~ad at M, 65000 wa~ identilied by $DS-PAG[~ after xoluhili~ttion of the li$aod.bindinlt protein complex wlli~:h i~ coa~i~te=tl with the 
pretence or a sinsle cla=~ of bindin[1 ~ite~ ~n rat lutl$ membrane~, Th~ band was undetectahle when I/m~oltl GLP-I [?.o36)amide was included in 
the binding assay. Ha change in the mohilit~ or'the hand wag observed under reducing ~ondition~ su=gesting thai the binding protein in the receptor 
is not part of a larger disulphide.linked prolein, The intensity of the ridiolab~lled protein band wa~ reduced when the incubation with i== |.lobe|led 
GLP-l(?~36)amide was carried out in the presence of guanine nucleotides sugg©stin8 th'~t the G LP, ICI 36)amidc receptor is cot=pied to th~ adenylale 
cyc|ttse syslcnt. 
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I. I N T R O D U C T I O N  
Glucagon - l i ke  peptide-l(7-36)amide (GLP- I )  is a 
p o s t t r a n s i a t i o n a l  process ing  p roduc t  o f  p rog lucagon  in 
the  m a m m a l i a n  in tes t ine  [1-3]. The  a m i n o  acid se- 
q u e n c e  o f  G L P - I  was  kept  dur ing  evo lu t ion  and  is iden- 
t ical in d i f ferent  m a m m a l s  inc lud ing  m a n  [4-6], This  in- 
d icates  an  i m p o r t a n t  biological  m e a n i n g  of  G L P - I  at 
least in m a m m a l s ,  In  previous studies,  it has beer  
sh own  that  GLP-1  is released m response  to oral  glucose 
a n d  poten t ly  s t imula tes  the g lucose- induced  insulin 
secre t ion  [7-9]. Thus ,  GLP .1  is cons idered  to be a new 
incre t in  cand ida te  be,tides the gastric inh ib i to ry  peptide 
(GIP) ,  F u r t h e r m o r e ,  G L P - I  is a s t rong  inh ib i to r  of the 
pen t agas t r i n - s t imu la t ed  gastric acid secret ion and 
the re fo re  cons idered  to be an  en te rogas t rone  candida te  
[10,11], C o r r e s p o n d i n g  to these data ,  receptors for 
G L P - i  have been ident i f ied  on ra t  i n su l inoma .de r ived  
R I N m S F  cells and  isolated gastric g lands  of  the rat 
[12,13]. Recent ly ,  we demons t r a t ed  specific b ind ing  
sites for G L P . 1 ( 7 - 3 5 )  amide  o n  rat lung m e m b r a n e s  
[14]. The  present  s tudy  describes the use of  a covalent  
c ross - l ink ing  reagent  to  fur ther  character ize  the l igand-  
b i n d i n g  c o m p o n e n t  o r t h e  G L P - I  receptor  on  rat lung  
m e m b r a n e s .  
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2. M A T E R I A L S  A N D  M E T H O D S  
2, I, Reagettrx 
GLP-1(7-36)amide was purchased from Peninsula Laboratories 
(St, Helens, Merseyside, UK), Disuccinimidyl suberate was from 
Pierce Europe BV (Oud.Beijerland, The Netherlands), GTP-?.S and 
GDP-t~-S were from Sigma Chemicals (Deisenhofen Germany) t='~l- 
labelled GLP-I ('/-36) :tmide (spec. act, 74 TBqlmmol) was prepared 
as described by G~Ike and Contort [12], 
2,2, Cell~' 
RINmSF cells were grown in plast ic culture bottles under the condb 
lions described by Praz et al, [15] The cells were detached fronl the 
surface of tl~e bottles before experimentation using phosphate- 
buffered saline (NaCl 136 retool/l, KCI 2,7 tnmol/l. Na.HPO,8 8.1 
retool/I, KH 2PO~ 1,5 retool/l: DH 7,3) cont:fining 0,7 ,nmol/l EDTA,, 
Cell concentrations were determined either by using a Neubauer 
haemocytomcter or by measurement or cellular DNA [16]. 
2,3 Membrane preparalion 
Plasma membranes of RINmSF cells were prepared as described 
previously [17], Briefly, approximately 6x 10 a RINmSF cells were 
suspended in 30 ml ice-cold homogenization buffer (Tris-HCI 10 
retool/I, NaCI 30 retool/l, dithiothreitol I retool/l, phenylmethyl- 
sulphonylfluoride (PMSF) 5 gmol/I; pH 7,5) and disrupted using a 
tight-fitting glass-glass homogenizer with six passages at 150 rpm, 
Rat lung membranes were prepared as described in detail previously 
[14], Male albino Wistar rats (200-220 g body weight) were killed by 
decapitation, tl~e lungs were removed and homogemzed in 
homogenization buffet" with an Ultra.Turrax followed by a further 
I~omogenization using a glass-glass homogenizer. 
Tile following steps in the preparation of RINmSF cell plasma 
membranes and rat lung membranes were identical. The I~omogenate 
was layered over a 41o/0 (w/v) sucrose solution and centrifuged for ¢50 
min at 4 ° at 95000 x g, The band at the interface of the layers 
represented the membranes and was collected, d [luted and centrifuged 
for 30 rain at 40000 x g. The pellet was resuspended in a modified 
Krebs-Ringer buffer (KRB) (Tris-HCl 2,5 retool/l, NaCI 120 mmol/I, 
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Fill, I Effect of gluealton.like pel~tide-ltT-;16)itnlidc (G1..1).1(7-36) • 
amitle on the cross.lhiking or 'I~I.(~LP- I (7-361amide Io ll~, re~gelilOr ill 
rill hmtl plasma membranes. Equal aliquol~t or membrane~ were 
incubated with tracer in the absence (D} anti presence of  0.1 nmol/I 
(C), I0 nmol#l (B) and I000 nmol#l (A) GLP.ltT-~16},~mtide, 
Experiment was ciirried out its described in section 2, Tile num oers 
show the mobilitles of phosphorylase h (hi, 94000), human ~erum 
albumin (M, 67 0O0), ovalbumin (M, 4~ CO0) and trypsin Inhibitor (M, 
20100), 
MaSO~ 1,2 retool/I, KCI 5 mmol#l, CFI)COONa I~ retool/I; pH 7,4) 
Containing I% (w/v) human serum albumin, 0.1% (w/v) baeitracin 
and EDTA I rnmol/I, frozen in liquid nitrogen and stored at -80"C.  
Protein concentration was determined as described by Bradford [18], 
2,4 Cross.linking e.vperiments 
Plasma membranes (200 ~g) were incubated will~ =~l.labelled 
GLP-1(7-36)amide (approximately 40000 cpm; spec. act. approx, 74 
TBq/mmol) in Hepes buffer (50 retool/I; pH 7,5) containing 0.02% 
(w/v} hunaan serum albumin for 30 rain at 37"C, lncubalions were 
also carried out in the presence of a range of concentrations of 
unlabelled GLP-l(7-36)amide or in the presence of guanine 
nucleotides as indicated. Incubations were terminated by centrifu~a- 
lion (10000 x g for 5 rain at 4"C) and pellets resuspended in ice.cold 
Hepes buffer (10 retool/I; pH 9,0) containing 0.02%0 (w/v) human 
serum albumin. 
A solution of disuccinimidyl suberate in dimethylsulphoxide was 
added to give a 0.1 mM final concentration 17] After incubation for 
10 rain at 4°C the reaction was stopped by addition of ammonium 
acetate solution (final concentration 10 retool/I), Membranes were 
centrifuged (10000 x g for 5 rain at 4°C) and the pellets resuspended 
in Hepes buffer (10 retool/l; pH 7,5) containing 0.02%0 human serum 
albumin, An incubation for 30 rain at 25°C was carried outin order 
to dissociate non-covalently bound ligand, After centrifugation 
(10000 x g for 5 rain at 4°C), the pellets were suspended in sodium 
phosphate buffer (10 retool/I; pH 7,5) containin~ 2%0 (w/v) sodium 
dodecylsulphate (SDS). Samples were boiled for 5 min in the presence 
and absence of 5%0 (v/v) mercaptoethanol, Electrophores~s was car- 
ried out using the discontinuous buffer system described by Laernmli 
[19] with a 4% acrylamide stacking gel and a 1007o acrylamide 
separating gel, The gels were calibrated using a molecular wei~,ht 
marker kit from Pharmacia, Uppsala, Sweden. Gels were dried and 
exposed to Kodak type X-Omat AR film for 2 weeks at -80°C using 
an image-i~atcnsifying screen. 
3. RESULTS 
Incubation of lung membranes with tzSI-labelled 
GLP-l(7-36)amide followed by chemical cross-linking 
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Fig. 2 Effect or =uanine nucleotides on the cross-linking of l=~l. 
Gt.P. l (?-36]amide to i ts receptor in rat lunl~ plasma membranes, 
Equal aliqaots or membranes were incubated as described in section 
2 in tile absence (C) and pre~enee (B) of  O, I mmol#l GTP.,~-S and O, I 
mmol / I  GDP.#.S (A), The numbers show the mobilities of  
ptlOSpltorylas¢ h (M, 94000), human serum albumin (Mr 67000), 
ovalbnmia (M, 43 00O) arid trypsin inhibitor (M, 20 100). 
and solubilization has identified a single ligand-binding 
protein complex of Mr 66000 ± 1000 (n=6)  (Fig. 1), 
The intensity of the radiolabelled band was reduced 
when the incubation with tZ~l-labelled GLP-I(7-36) 
amide was carried out in the presence of  increasing con- 
centrations of unlabelled GLP.l(7-36)amide. At 1 
#mol/l  unlabelled GLP-l(7-36)amide no band was 
detectable anymore (Fig. 1). When experiments were 
carried out in the absence of  rat lung membranes no 
radioactive labelled band was detectable in the gel. In- 
cubations carried out in the presence of GTP-3,-S (0.1 
retool/l) or GDP-f3-S (0.1 mmol/l)  resulted in a reduc- 
tion of  the specific receptor linked tracer binding (Fig. 
2). 
A solubilization of  the cross-linked receptor/ligand 
complex under reducing conditions did not lead to a 
change of the motility of the labelled M, 66000 band 
(Fig. 3). 
Previously, we characterized GLP-1 receptors on 
RINm5F plasma membranes by covalent cross-linking 
[17]. Experiments carried out to compare cross-linked 
and solubilized GLP-1 receptor-ligand complexes from 
rat lung and RINmSF membranes revealed no signifi- 
cant difference in the molecular weight of the ligand- 
binding protein complexes (Fig. 4). 
Vasoactive intestinal peptide (VIP) and peptide 
histidine isoleucine (PHI) are able to displace 125I- 
GLP- ] (7-36)amtde from rat lung membranes with a Kd 
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Fi~. 3. Effect or snlubili~alion mld~r reclucm~] conditions on the cross. 
linkintl or ~l.GLP.it'~-36)amid~: to i(s receptor in rat lun8 plasma 
mcmbrm~cs. Solubilixafion was carried out in the presence (A,B) nnd 
absence (C,D) er St';* iv/v) l:l.mercal)lOethanol, Incubations were 
carried out in the absence (B,D) and presence (A,C] of I ~rnol/l 
GLP-ItT-36)~mfide, The mtmbcrs slmw the mobilities of 
pllosphoryhsse h (M, 94 000), human scrum albumin (M, 6"/000] ~md 
ovalbumin (b,1, 43000). 
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Fit~. 4, CompcLrlson or the cross-linkinl! or ==~I.GL.P. l(7-]6)amldc to 
its receptor irl ra( lunll (A,B] and RINmH= (C,D) plasma n~cmbranes, 
Ineubalions were carried out as described in section 2 In Ihe presence 
(A,C} and absence (B,D) of I ,arnol/I GLP.l(7-,]6}amide The 
tmmbers :dlow the mobilitics or phosphorylase b (M, ~4000), human 
serum albumin tM, 6"/000) and ovalbumin (hi, 43000). 
which is 2,5 and 4.7 times less, respectively, than that  o f  
GLP-IC7-36)amide  [14]. We then  incubated rat lung  
membranes  (1 mg prote in/ml)  with t ~ I -VIP  in the 
presence and absence of  GLP- l (7 -36)amide ,  
G L P - l ( 7 - 3 6 ) a m i d e  did not displace *2~I-VIP f rom its 
b inding to rat lung membranes  (data not shown), 
4. D I S C U S S I O N  
Recently, we demonst ra ted  the presence o f  a single 
class of  high affini ty receptors for G L P - l ( 7 - 3 6 ) a m i d e  
on rat  lung membranes  [14]. Consistent with this result 
only  a single protein with Mr 66000 was aff ini ty-  
labelled using the cross-linking agent disuccinimidyl 
subera te  which is reactive towards arnino groups  and 
has found widespread application in the characteriza- 
t ion of  binding proteins for neurohormona l  peptides 
[20-25] .  Evidence that  the tracer bound to a componen t  
o f  the GLP-1 receptor  was obtained by the fact that  
labelling of  the protein was inhibited by increasing con- 
centrat ions of  unlabelled GLP- l (7 -36)amide .  
Solubil ization of  the receptor / l igand complex under  
reducing condit ions did not lead to a change of  the 
mot i l i ty  of the labelled band suggesting that the binding 
c o m p o n e n t  for GLP- l (7 -36 )amide  in rat lung mem-  
branes  is not a par t  o f  a larger disulphide-linked pro-  
tein. 
Recently, we repor ted that b inding of t2Sl- 
G L P - l ( 7 - 3 6 ) a m i d e  to Lung membranes  is decreased in 
the presence of  guanine nucleotides [14]. Conf i rming 
these data ,  we demons t ra te  now that incubations in the 
presence of guanine nucleotides resulted in a reduction 
of  the specific receptor linked tracer binding. This sup- 
ports  the assumpt ion that in rat h m g  membranes  
GLP- l (7 -36 )amide  receptors are also linked to the 
adenyla te  cyclase system. 
The  data of  this s tudy are very similar to results we  
obta ined with GLP-1CT-36)amide receptors f rom 
R I N m S F  plasma membranes  in a previous study [17]. 
Directly compared  both receptors exhibited the same 
molecular  weight. Thus ,  it seems tha t  GLP- l (7 -36 ) -  
amide  receptors in R I N m 5 F  and rat lung plasma mem-  
branes  do not differ  due to their biochemical  proper-  
ties. 
Interestingly, the binding affinity of  GLP- I (7 -36 ) -  
amide  on rat lung receptors is 10 times less compared  to 
receptors  on R I N m S F  membranes  [14]. Fur thermore ,  
vasoact ive intestinal peptide (VIP)  and peptide histidine 
isoleucin (PHI )  do not bind to G L P - l ( 7 - 3 6 ) a m i d e  
receptors  on R I N m 5 F  membranes  but  are able to 
displace Iz~I-GLP-l(7-36)amide f rom rat lung mem-  
branes  with a Kd which is only 2.5 and 4.? times, respec- 
tively, less than  that  o f  G L P - l ( 7 - 3 6 ) a m i d e  [14] while 
~2SI-VIP is not displaced by GLP- l (7 -36 )amid e  f rom 
rat  lung membranes .  
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